Predictive Oncology Inc. (POAI) Earnings History
Annual and quarterly earnings data from 2008 to 2024
Loading earnings history...
POAI EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
POAI Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2024 | 49.1% | -673.7% | -751.4% |
| 2023 | 62.6% | -744.5% | -859.1% |
| 2022 | 66.4% | -1729.3% | -1709.6% |
| 2021 | 65.7% | -1437.9% | -1383.6% |
| 2020 | 64.3% | -2025.1% | -2067.0% |
Download Data
Export POAI earnings history in CSV or JSON format
Free sign-in required to download data
Predictive Oncology Inc. (POAI) Earnings Overview
As of May 8, 2026, Predictive Oncology Inc. (POAI) reported trailing twelve-month net income of -$84M, reflecting +35.6% year-over-year growth. The company earned $-116.48 per diluted share over the past four quarters, with a net profit margin of -751.4%.
Looking at the long-term picture, POAI's historical earnings data spans multiple years. The company achieved its highest annual net income of -$1M in fiscal 2010.
Predictive Oncology Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including RXRX (-$560M net income, -863.4% margin), ABSI (-$118M net income, -4113.7% margin), SDGR (-$103M net income, -40.4% margin), POAI has outperformed on profitability metrics. Compare POAI vs RXRX →
POAI Earnings vs Peers
Earnings metrics vs comparable public companies
POAI Historical Earnings Data (2008–2024)
17 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | -$12M | +12.7% | -$11M | $-2.24 | -751.4% | -673.7% |
| 2023 | -$14M | +45.7% | -$12M | $-3.48 | -859.1% | -744.5% |
| 2022 | -$26M | -30.9% | -$26M | $-6.98 | -1709.6% | -1729.3% |
| 2021 | -$20M | +24.1% | -$20M | $-7.20 | -1383.6% | -1437.9% |
| 2020 | -$26M | -33.5% | -$25M | $-44.25 | -2067.0% | -2025.1% |
| 2019 | -$19M | -92.2% | -$23M | $-137.20 | -1373.7% | -1604.2% |
| 2018 | -$10M | -30.2% | -$8M | $-157.40 | -714.5% | -556.9% |
| 2017 | -$8M | -18.7% | -$8M | $-188.69 | -1183.0% | -1183.0% |
| 2016 | -$7M | -36.2% | -$7M | $-462.28 | -1429.6% | -1429.6% |
| 2015 | -$5M | +29.9% | -$4M | $-306.79 | -732.1% | -672.4% |
See POAI's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs POAI Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare POAI vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonPOAI — Frequently Asked Questions
Quick answers to the most common questions about buying POAI stock.
Is POAI growing earnings?
POAI EPS is $-116.48, with earnings growth accelerating to +35.6%. This exceeds the 5-year CAGR of N/A. TTM net income reached $-84M.
What are POAI's profit margins?
Predictive Oncology Inc. net margin is -751.4%, with operating margin at -673.7%. Below-average margins reflect competitive or cost pressures.
How consistent are POAI's earnings?
POAI earnings data spans 2008-2024. The accelerating earnings trend is +35.6% YoY. Historical data enables comparison across business cycles.